(Q38263111)

1 September 2017

1 reference

title

Medulloblastoma-translating discoveries from the bench to the bedside (English)

1 reference

1 September 2017

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25348790%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

Amar J Gajjar

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25348790%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

language of work or name

English

0 references

publication date

28 October 2014

1 reference

Nature Reviews Clinical Oncology

1 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25348790%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25348790%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25348790%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

714-722

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25348790%20AND%20SRC:MED&resulttype=core&format=json

Challenging issues in pediatric oncology

7 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Treatment of early childhood medulloblastoma by postoperative chemotherapy alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Late neurocognitive sequelae in survivors of brain tumours in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Medulloblastoma in childhood: progressive intellectual deterioration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Cardiorespiratory fitness in survivors of pediatric posterior fossa tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Long-term outcomes among adult survivors of childhood central nervous system malignancies in the Childhood Cancer Survivor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Serial evaluation of academic and behavioral outcome after treatment with cranial radiation in childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Prediction of central nervous system embryonal tumour outcome based on gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

The 2007 WHO classification of tumours of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Childhood medulloblastoma: novel approaches to the classification of a heterogeneous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Morphophenotypic variation predicts clinical behavior in childhood non-desmoplastic medulloblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Medulloblastoma comprises four distinct molecular variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Molecular subgroups of medulloblastoma: the current consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Medulloblastomics: the end of the beginning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

The clinical implications of medulloblastoma subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Beta-catenin hits chromatin: regulation of Wnt target gene activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Novel mutations target distinct subgroups of medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Dissecting the genomic complexity underlying medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Medulloblastoma: signalling a change in treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Subtypes of medulloblastoma have distinct developmental origins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Signaling from Smo to Ci/Gli: conservation and divergence of Hedgehog pathways from Drosophila to vertebrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Altered neural cell fates and medulloblastoma in mouse patched mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Mutations in SUFU predispose to medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Subgroup-specific structural variation across 1,000 medulloblastoma genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Cytogenetic prognostication within medulloblastoma subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Sonic hedgehog-associated medulloblastoma arising from the cochlear nuclei of the brainstem.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinct

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Hedgehog fights back: mechanisms of acquired resistance against Smoothened antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

A mouse model of the most aggressive subgroup of human medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

An animal model of MYC-driven medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Pemetrexed and gemcitabine as combination therapy for the treatment of Group3 medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

BET bromodomain inhibition of MYC-amplified medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Induction chemotherapy and conformal radiation therapy for very young children with nonmetastatic medulloblastoma: Children's Oncology Group study P9934.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Update on molecular and genetic alterations in adult medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Whole-brain irradiation and decline in intelligence: the influence of dose and age on IQ score

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Physical performance limitations and participation restrictions among cancer survivors: a population-based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181

Histopathologic grading of medulloblastomas: a Pediatric Oncology Group study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.181